Cellular accumulation determines the activity of three novel tricyclic platinum agents

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 2039-2043

  Gangopadhyay, S B ^a   Roendigs, A ^a   Kangarloo, S B ^a   Krebs, B ^a   Wolff, J E A ^a  

^a Klinik St Hedwing   (Germany)

Author keywords

Atomic absorption spectrometer; Cisplatin; Glioma cells; Platinum analogues

Indexed keywords

AMINOPLATIN; CISPLATIN; METHYLPLATIN; OXIPLATIN; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DRUG ACCUMULATION; DRUG PENETRATION; DRUG SYNTHESIS; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINOPYRIDINES; ANTINEOPLASTIC AGENTS; BINDING SITES; BRAIN NEOPLASMS; CELL SURVIVAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GLIOMA; HUMANS; MODELS, CHEMICAL; ORGANOPLATINUM COMPOUNDS; PLASMIDS; PLATINUM COMPOUNDS; PYRIDINES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034897493     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair
2. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma
3. Accumulation of cis-diamminedichloroplatinum (11) and platinum analogues by platinum-resistant murine leukemia cells in vitro
4. Glutathione metabolism as a determinant of therapeutic efficacy: A review
5. Enhanced DNA repair as a mechanism of resistance to cis- Diammine dichloroplatinum (II)
6. High mobility group proteins 1 and 2 function as general class II transcription factors
7. Transcription factor Y-box binding protein I binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
8. Cisplatin and DNA repair in chemotherapy
9. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA
10. Effect of polyoxoanions on malignant glioma cells
11. Binding of an antitumor platinum compound to cells as influenced by physical factors and pharmacologically active agents
12. Cisplatin uptake mediated cisplatin-resistance in human ovarian carcinoma cells. Platinum and other metal co-ordination compounds in cancer chemotherapy
13. Reduction of cis-dichlorodiammineplatinum (II)-induced cell inactivation by benzaldehyde
14. Synergistic cell inactivation by cis-dichlorodiammineplatinum (II) in combination with 1-propargyl-5-chloropyrimidin-2-one
15. Increased sensitivity, to cis-iamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tatradecanoylphorbol 13-acatate
16. Active transport properties of porcine choroid plexus cells in culture